Wei, J.; Kurumi, H.; Isomoto, H.; Ogihara, R.; Matsushima, K.; Machida, H.; Ishida, T.; Hirayama, T.; Yamaguchi, N.; Yoshida, Y.;
et al. Toll-like Receptor Gene Polymorphisms as Predictive Biomarkers for Response to Infliximab in Japanese Patients with Crohn’s Disease. Diagnostics 2025, 15, 971.
https://doi.org/10.3390/diagnostics15080971
AMA Style
Wei J, Kurumi H, Isomoto H, Ogihara R, Matsushima K, Machida H, Ishida T, Hirayama T, Yamaguchi N, Yoshida Y,
et al. Toll-like Receptor Gene Polymorphisms as Predictive Biomarkers for Response to Infliximab in Japanese Patients with Crohn’s Disease. Diagnostics. 2025; 15(8):971.
https://doi.org/10.3390/diagnostics15080971
Chicago/Turabian Style
Wei, Jingjing, Hiroki Kurumi, Hajime Isomoto, Ryohei Ogihara, Kayoko Matsushima, Haruhisa Machida, Tetsuya Ishida, Tatsuro Hirayama, Naoyuki Yamaguchi, Yukina Yoshida,
and et al. 2025. "Toll-like Receptor Gene Polymorphisms as Predictive Biomarkers for Response to Infliximab in Japanese Patients with Crohn’s Disease" Diagnostics 15, no. 8: 971.
https://doi.org/10.3390/diagnostics15080971
APA Style
Wei, J., Kurumi, H., Isomoto, H., Ogihara, R., Matsushima, K., Machida, H., Ishida, T., Hirayama, T., Yamaguchi, N., Yoshida, Y., & Tsukamoto, K.
(2025). Toll-like Receptor Gene Polymorphisms as Predictive Biomarkers for Response to Infliximab in Japanese Patients with Crohn’s Disease. Diagnostics, 15(8), 971.
https://doi.org/10.3390/diagnostics15080971
